Journal Club Reports

TBA

Date: 
February 28, 2012
Time: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Clinton Ho

SESSION CANCELLED

Date: 
December 27, 2011

DONOR DEFERRAL: A QUALITATIVE APPROACH

Date: 
December 20, 2011
Time: 
12:00 - 1:00 p.m.
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Arjuna Ponnampalam
Objectives:
1.      Introduction to Qualitative research methodology
2.      Understanding the meaning of permanent deferral for blood donors – Whittaker et al.

Session Cancelled

Date: 
December 6, 2011
Speaker(s): 
N/A

 Transfusion Medicine Resident Education Seminar

 Tuesday, December 6, 2011

CANCELLED

Treatment of neonatal sepsis with intravenous immune globulin

Date: 
November 1, 2011
Time: 
12:00 - 1:00 p.m.
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Lani Lieberman
Objectives:
1)      To highlight the clinical implication of sepsis in the neonatal population.
2)      To review the impact of immune globulin in neonatal septic outcomes.
Downloads: 

Granulocyte transusions for preventing infections in patients with neutropenia or neutrophil dysfunction (Review)

Date: 
October 4, 2011
Time: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Christopher Sharpe
Objectives:
1.      To highlight the clinical implications of neutropenia

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial.

Date: 
May 3, 2011
Time: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Christopher Sharpe
Objectives:
1.   To discuss the role of tranexamic acid in coagulation/fibrinolysis
2.   To discuss the role of tranexamic acid in the prevention of bleeding during surgery and other clinical settings

"Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure” Rios JA, Schlumpf KS, Kakaiya RM, et al. Transfusion 2011

Date: 
March 1, 2011
Time: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Christopher Sharpe
Objectives:
1.      To discuss the impact of deferring female plasma and platelet apheresis donors on blood component availability in the US
2.      To discuss TRALI-mitigation strategies (including current CBS policy)

The Effect of Prophylactic Platelet Dose on Severe Hypoproliferative Thrombocytopenia

Date: 
January 25, 2011
Time: 
12:00 - 1:00 p.m. Eastern
Location: 
1-866-752-7690 ID 1775282
Speaker(s): 
Dr. Areej Almugairi
Objectives:
1       Overview of the platelet transfusion guidelines.
2       Discuss the available evidence for the optimal prophylactic platelet dose to prevent bleeding in chemotherapy induced thrombocytopenia
Downloads: 
Syndicate content

Text will be replaced with image replacement